Granulocyte transfusion therapy

Current Opinion in Hematology

Volumn 6, Issue 1, 1999, Pages 3-7

  Schiffer, Charles A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOIMMUNIZATION; ANTIBIOTIC THERAPY; GRANULOCYTE TRANSFUSION; GRANULOCYTOPENIA; GRANULOCYTOSIS; HISTOCOMPATIBILITY; HUMAN; INFECTION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

AGRANULOCYTOSIS; BLOOD COMPONENT TRANSFUSION; GRANULOCYTES; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0032908951     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199901000-00002     Document Type: Review

References (41)

1. 1 Klein HG, Strauss RG, Schiffer CA: Granulocyte transfusion therapy. Semin Hematol 1996, 33:359-368.
2. 2 Dale DC: Annotation: Renewed interest in granulocyte transfusion therapy. Br J Haematol 1997, 98:497-501.
3. 3 Schiffer CA: Granulocyte transfusions: an overlooked therapeutic modality. Transfus Med Rev 1990, 4:2-7.
4. 4 Strauss RG: Therapeutic granulocyte transfusions in 1993. Blood 1993, 81:1675-1678.
5. 5 Bodey GP, Buckley M, Sathe YS, Freireich EJ: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966, 64:328-340.
6. 6 Freireich EJ, Levin RH, Whang J, Carbone PP, Bronson W, Morse EE: The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann N Y Acad Sci 1964, 113:1081-1089.
7. 7 Eyre HJ, Goldstein IM, Perry S, Graw Jr RG: Leukocyte transfusions: function of transfused granulocytes from donors with chronic myelocytic leukemia. Blood 1970, 36:432-442.
8. 8 Schiffer CA, Buchholz DH, Aisner J, Betts SW, Wiernik PH: Clinical experience with transfusion of granulocytes obtained by continuous flow filtration leukopheresis. Am J Med 1975, 58:373-381.
9. 9 Graw Jr RG, Herzig G, Perry S, Henderson ES: Normal granulocyte transfusion therapy. N Engl J Med 1972, 287:367-371.
10. 10 Higby DJ, Yates JW, Henderson ES, Holland JF: Filtration leukopheresis for granulocyte transfusion therapy. N Engl J Med 1976, 292:761-766.
11. 11 Alavi JB, Root RK, Djerassi I, Evans AE, Gluckman SJ, MacGregor RR, et al.: A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 1977, 296:706-711.
12. 12 Vogler WR, Winton EF: A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977, 63:548-555.
13. 13 Herzig RG, Herzig GP, Graw Jr RG, Bull MI, Ray KK: Successful granulocyte transfusion therapy for gram-negative septicemia. N Engl J of Med 1977, 296:701-705.
14. 14 Vamvakas EC, Pineda AA: Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apheresis 1996, 11:1-9.
15. 15 Ruthe RC, Anderson BR, Cunningham BL, Epstein R: Efficacy of granulocyte transfusions in the control of systemic candidiasis in the leukopenic host. Blood 1978, 52:493-498.
16. 16 Epstein RB, Chow HS: An analysis of quantitative relationships of granulocyte transfusion therapy in canines. Transfusion 1981, 21:360-362.
17. 17 Appelbaum FR, Bowles CA, Makuch RW, Deisseroth AB: Granulocyte transfusion therapy of experimental pseudomonas septicemia: study of cell dose and collection technique. Blood 1978, 52:323-331.
18. 18 Winston DJ, Ho WG, Gale RP: Therapeutic granulocyte transfusions for documented infections. Ann Intern Med 1982, 97:509-515.
19. 111Indium-labeled granulocytes to sites of infection. Blood 1983, 62:354-360.
20. 20 McCullough J, Weiblen BJ, Clay ME, Forstrom L: Effect of leukocyte anti-bodies on the fate in vivo of indium-111 -labeled granulocytes. Blood 1981, 58:164-170.
21. 21 Schiffer CA, Aisner J, Dutcher JP, Wiernik PH: Sustained post transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia. Am J Hematol 1983, 15:65-74.
22. 22 Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, et al.: The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukopheresis. Blood 1993, 81:1883-1888.
23. 23 Caspar CB, Seger RA, Burger J, Gmhr J: Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993, 81:2866-2871.
24. 24 Leitman SF, Oblitas JM, Emmons R, Dunn DE, Young NS: Clinical efficacy of daily G-CSF-recruited granulocyte transfusions in patients with severe neutropenia and life-threatening infections. Blood 1996, 88(suppl):1313.
25. 25 Hester JP, Dignani MC, Anaissie EJ, Kantarjian HM, O'Brien S, Freireich EJ: Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis 1995, 10:188-193.
26. 26 Liles WC, Huang JE, Llewellyn C, SenGupta D, Price TH, Dale DC: A comparative trial of granulocyte colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion 1997, 37:182-187. Dexamethasone 8 mg given with G-CSF 600 μg/kg increased neutrophil counts 12 hours after administration to a much greater extent than either drug alone. This is a convenient regimen for preparing donors for collection the next day.
27. 27 Nomura A, Ohga S, Matsuzaki A, Kai T, Inaba S, Suda M, Ueda K: Granulocyte transfusion: stimulation of low dose granulocyte colony-stimulating factor in donors for leukopheresis. Acta Paediatr Jpn 1996. 38:317-321.
28. 28 de Hass M, Kerst JM, van der School E, Calafat J, Hack CE, Nuijens JH, et al.: Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 1994, 84:3885-3894.
29. 29 Lee JH, Leitman SF, Klein HG: A controlled comparison of the efficacy of hetastarch and pentastarch in granulocyte collections by centrifugal leukopheresis. Blood 1995, 86:4662-4666.
30. 30 Adkins D, Ali S, Despotis G, Dynis M, Goodnough LT: Granulocyte collection efficiency and yield are enhanced by the use of a higher interface offset during apheresis of donors given granulocyte colony-stimulating factor.Transfusion 1998, 38:557-564.
31. 31 Rex JH, Ghalla SC, Cohen DM, Hester JP, Vartivarian SE, Anaissie EJ: Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by interferon-gamma and granulocyte colony-stimulating factor. Transfusion 1995, 35:605-611.
32. 32 Dignani MC, Anaissie EJ, Hester JP, O'Brien S, Vartivarian SE, Rex JH, et al.: Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 1997, 11:1621 -1630. This appears to be a somewhat more detailed description of the patients described in Hester et al. [25].
33. 33 Adkins D, Goodgold H, Hendershott L, Johnston M, Cravens D, Spitzer G: Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transpl 1997, 19:809-812. Indium-labeled granulocytes collected after 5 days of donor treatment with G-CSF were capable of migration to sites of infection, providing inferential evidence of their normal function in vivo.
34. 34 Catalano L, Fontana R, Scarpato N, Picardi M, Rocco S, Rotoli B: Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation. Haematologica 1997, 82:71-72. A patient with invasive Aspergillus infection before transplantation was successfully supported with multiple granulocyte transfusions during this period of aplasia.
35. 35 Grigg A, Lusk J, Szer J: G-CSF stimulated donor granulocyte collections for netropenic sepsis. Leuk Lymphoma 1995, 18:329-334.
36. 36 Wright DG, Robichaud KJ, Pizzo P, Deisseroth AB: Lethal pulmonary reactions associated with the combined use of amphotercin B and leukocyte transfusions. N Engl J Med 1981, 304:1185-1189.
37. 37 Dutcher JP, Kendall J, Papenberg D, Schiffer CA, Aisner J, Wiernik PH: Granulocyte transfusion therapy and amphotericin B-adverse reactions? Am J Hematol 1989, 31:102-108.
38. 38 Vamvakas EC, Pineda AA: Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apheresis 1997, 12:74-81. The conclusions of this attempt at meta-analysis of older clinical trials are consistent with earlier observations suggesting the importance of granulocyte dose and donor and recipient histocompatibility. Given the extreme heterogeneity of these trials, however, the power of the statistical analyses is probably somewhat weak.
39. 39 Stroncek DF: Granulocyte immunology: is there a need to know? Transfusion 1997, 37:866-888.
40. 40 Schiffer CA, Aisner J, Daly PA, Schimpff SC, Wiernik PH: Alloimmunization following prophylactic granulocyte transfusion. Blood 1979, 54:766-774.
41. 41 Winston DJ, Ho WG, Howell CL, Miller MJ, Mickey R, Martin WJ, et al.: Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med 1980, 93:671-675.